A propective randomized split-mouth study with modified and conventional sandblasted acid-etched implants in irradiated oral squamous cell carcinoma patients

A propective randomized split-mouth study with modified and conventional sandblasted acid-etched implants in irradiated oral squamous cell carcinoma patients - ICX

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025177

Enrollment

Registered

2021-04-27

Start date

2021-04-27

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.2

Interventions

Group 1: ICX-Active Liquid Implant Group 2: ICX-Active Master Implant

Eligibility

Sex/Gender

All

Age

20 Years to 99 Years

Inclusion criteria

Inclusion criteria: indication for Implantation irradiated oral squamous cell carcinoma patients

Exclusion criteria

Exclusion criteria: smoker

Design outcomes

Primary

Measure	Time frame
6 month after implant Insertion standardized orthopantomographies and clinical parameters like pocket depths, mPII and mBI were evaluated	—

Secondary

Measure	Time frame
12 month after implant Insertion standardized orthopantomographies and clinical parameters like pocket depths, mPII and mBI were evaluated	—

Countries

Germany

Contacts

Public ContactSusanne Nahles

Charité CVK Klinik für MKG-Chirurgie

susanne.nahles@charite.de030450555022

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026